| Factor Information | |
|---|---|
| Data ID | 39 |
| Factor | Cord blood BNP |
| Description | The median cord blood BNP was significantly higher in the case subgroup without 6-month infant survival than in the case subgroup with 6-month surviva |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the predict value of cord blood B-type natriuretic peptide and pH values with adverse outcomes |
| p Value | <0.05 |
| Conclusion | Our study indicate that high cord blood BNP levels may reflect fetal CHD, and even higher levels may possibly predict a poorer outcome among neonates with CHD. |
| Risk Factor | protective factor |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 31256695 |
| Year | 2019 |
| Title | Maternal and cord blood homocysteine, vitamin B12, folate, and B-type natriuretic peptide levels at term for predicting congenital heart disease of the neonate: A case-control study |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | cord blood | |
| Region | Ankara, Turkey | |
| Method | a chemiluminescent microparticle immunoassay | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | case group without 6-month fetal survival(Treatment) | case group with 6-month fetal survival(Control) |
| Number | 8 | 30 |
| Age | 29.79±4.49 (19–39)years(group with fetal CHD) | 29.79±4.49 (19–39)years(group with fetal CHD) |
| Gender (Male: Female) | 0:8 | 0:30 |
| Marker Level | 125 (150.20) pg/ml | 31.90 (33.20)pg/ml(case group with 6-month fetal survival) |
